Our results demonstrate that GnRH-AIF chimeric proteins are a potent and specific modality for targeted treatment of solid cancers that overexpress the GnRH-R, such as colon cancer, via a caspase-independent mechanism. This evidence concerns the gene GNRHR and malignant colon neoplasm.